Effect of photobiomodulation and botulinum toxin type a on temporomandibular joint monoarthritis: an in vivo study

Temporomandibular disorders (TMDs) are often accompanied by inflammatory conditions such as joint monoarthritis that cause progressive structural degradation. However, conventional monotherapies offer only limited relief, but combined neurotoxin and biomodulatory approaches are a promising alternative that needs systematic histological evaluation. The aim of this study was to evaluate the histological and Histomorphometric effect of combined photobiomodulation (PBM) and botulinum toxin type-A (BTX-A) compared to the monotherapy of each treatment in a rat model of complete Freund's adjuvant (CFA)-induced temporomandibular joint (TMJ) monoarthritis. Forty Wistar male rats were injected unilaterally with 100 µL (1 mg/mL) of complete Freund's adjuvant (CFA) intra-articularly in the left temporomandibular joint (TMJ) area and then divided into four groups: untreated CFA control group, PBM received group (980 nm, 0.5 W, 20 J/cm², four sessions), BTX-A injection group (5 units intramuscular) and combined PBM + BTX-A group. Three weeks after CFA injection, mandibular condyles, synovial tissue and masseter muscles were harvested for histological analysis. The combined therapy group achieved superior results in organization of cartilage zones, subchondral bone architecture, synovial membrane architecture and muscle fiber alignment in comparison with the active untreated TMJ monoarthritis group (Group I). Moreover, the combined PBM + BTX-A group had a significantly lower chondroblastic thickness and significantly higher hypertrophic thickness compared to all other groups (p < 0.05). Correlation analysis showed a strong positive correlation between the chondroblastic and hypertrophic zones only in the untreated CFA group (r = 0.934, p < 0.001). Combined PBM and BTX-A therapy demonstrated superior structural tissue recovery in an experimentally induced rat model of TMJ monoarthritis compared to monotherapies or untreated control, establishing an effective multimodal framework that addresses inflammatory and neuromuscular components of the disease simultaneously.

Authors

Institutions

Publication Details

Journal
Lasers in Medical Science
Published
2026-11-18
DOI
https://doi.org/10.1007/s10103-026-05101-1
Primary Topic
Temporomandibular Joint Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effect of photobiomodulation and botulinum toxin type a on temporomandibular joint monoarthritis: an in vivo study

Osama Fekry Al Balah, Stefano Benedicenti, Antonio Signore, Mostafa Gheith et al.
4 links
Lasers in Medical Science
Temporomandibular Joint Disorders
article

Effect of photobiomodulation and botulinum toxin type a on temporomandibular joint monoarthritis: an in vivo study

Osama Fekry Al Balah, Stefano Benedicenti, Antonio Signore, Mostafa Gheith, Nesrin Ahmed Emam, Sally Samir Aly Sakr
article en

Abstract

Temporomandibular disorders (TMDs) are often accompanied by inflammatory conditions such as joint monoarthritis that cause progressive structural degradation. However, conventional monotherapies offer only limited relief, but combined neurotoxin and biomodulatory approaches are a promising alternative that needs systematic histological evaluation. The aim of this study was to evaluate the histological and Histomorphometric effect of combined photobiomodulation (PBM) and botulinum toxin type-A (BTX-A) compared to the monotherapy of each treatment in a rat model of complete Freund's adjuvant (CFA)-induced temporomandibular joint (TMJ) monoarthritis. Forty Wistar male rats were injected unilaterally with 100 µL (1 mg/mL) of complete Freund's adjuvant (CFA) intra-articularly in the left temporomandibular joint (TMJ) area and then divided into four groups: untreated CFA control group, PBM received group (980 nm, 0.5 W, 20 J/cm², four sessions), BTX-A injection group (5 units intramuscular) and combined PBM + BTX-A group. Three weeks after CFA injection, mandibular condyles, synovial tissue and masseter muscles were harvested for histological analysis. The combined therapy group achieved superior results in organization of cartilage zones, subchondral bone architecture, synovial membrane architecture and muscle fiber alignment in comparison with the active untreated TMJ monoarthritis group (Group I). Moreover, the combined PBM + BTX-A group had a significantly lower chondroblastic thickness and significantly higher hypertrophic thickness compared to all other groups (p < 0.05). Correlation analysis showed a strong positive correlation between the chondroblastic and hypertrophic zones only in the untreated CFA group (r = 0.934, p < 0.001). Combined PBM and BTX-A therapy demonstrated superior structural tissue recovery in an experimentally induced rat model of TMJ monoarthritis compared to monotherapies or untreated control, establishing an effective multimodal framework that addresses inflammatory and neuromuscular components of the disease simultaneously.

Lasers in Medical ScienceVol. 41(1)
Cairo University (EG), Sechenov University (RU), Arab Academy for Science, Technology, and Maritime Transport (EG), University of Genoa (IT)
Good health and well-being
Temporomandibular Joint Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon